UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial

Clinical infectious diseases, 2015-08, Vol.61 (3), p.403-408

2015

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

AIDS (London), 2010-11, Vol.24 (18), p.2827-2833

2010

Link zum Volltext

Verfügbarkeit prüfen

Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis

AIDS research and therapy, 2023-02, Vol.20 (1), p.10-10, Article 10

2023

Link zum Volltext

Verfügbarkeit prüfen

Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables

PloS one, 2014-09, Vol.9 (9), p.e107625-e107625

2014

Link zum Volltext

Verfügbarkeit prüfen

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications

Clinical infectious diseases, 2010-05, Vol.50 (9), p.1300-1308

2010

Link zum Volltext

Verfügbarkeit prüfen

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

PloS one, 2014-12, Vol.9 (12), p.e114142-e114142

2014

Link zum Volltext

Verfügbarkeit prüfen

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

PloS one, 2014-02, Vol.9 (2), p.e84676

2014

Link zum Volltext

Verfügbarkeit prüfen

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

AIDS (London), 2012-11, Vol.26 (18), p.2285-2293

2012

Link zum Volltext

Verfügbarkeit prüfen

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy

Journal of antimicrobial chemotherapy, 2013-10, Vol.68 (10), p.2358-2362

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1

Expert opinion on pharmacotherapy, 2018-06, Vol.19 (8), p.929-934

2018

Link zum Volltext

Verfügbarkeit prüfen

Pilot Pharmacokinetic Study of Human Immunodeficiency Virus-Infected Patients Receiving Tenofovir Disoproxil Fumarate (TDF): Investigation of Systemic and Intracellular Interactions between TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.1937-1943

2009

Link zum Volltext

Verfügbarkeit prüfen

Immunodiscordant responses to HAART - mechanisms and consequences

Expert review of clinical immunology, 2013-11, Vol.9 (11), p.1135-1149

2013

Link zum Volltext

Verfügbarkeit prüfen

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine

Journal of antimicrobial chemotherapy, 2024-05, Vol.79 (5), p.1133-1141

2024

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis

PloS one, 2011-07, Vol.6 (7), p.e22003-e22003

2011

Link zum Volltext

Verfügbarkeit prüfen

Compromised Immunologic Recovery in Treatment-Experienced Patients with HIV Infection Receiving Both Tenofovir Disoproxil Fumarate and Didanosine in the TORO Studies

Clinical infectious diseases, 2005-09, Vol.41 (6), p.901-905

2005

Link zum Volltext

Verfügbarkeit prüfen

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels

Journal of antimicrobial chemotherapy, 2015-07, Vol.70 (7), p.2104-2107

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study

AIDS research and human retroviruses, 2007-10, Vol.23 (10), p.1166

2007

Link zum Volltext

Verfügbarkeit prüfen

Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery

PloS one, 2017-09, Vol.12 (9), p.e0184433-e0184433

2017

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes

AIDS (London), 2016-09, Vol.30 (15), p.2275-2287

2016

Link zum Volltext

Verfügbarkeit prüfen

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy

Antiviral research, 2012-10, Vol.96 (1), p.65-69

2012

Link zum Volltext

Verfügbarkeit prüfen

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery

Journal of translational medicine, 2015-07, Vol.13 (1), p.230-230, Article 230

2015

Link zum Volltext

Verfügbarkeit prüfen

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals

Journal of antimicrobial chemotherapy, 2017-03, Vol.72 (3), p.844-849

2017

Link zum Volltext

Verfügbarkeit prüfen

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

Journal of neurovirology, 2010-06, Vol.16 (3), p.208-218

2010

Link zum Volltext

Verfügbarkeit prüfen

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

BioMed research international, 2016-01, Vol.2016, p.4380845-5

2016

Link zum Volltext

Verfügbarkeit prüfen

Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study)

Journal of acquired immune deficiency syndromes (1999), 2005-01, Vol.38 (1), p.47

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

ThemaHiv Infections - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(102)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(102)
Science & Technology
(95)
Life Sciences & Biomedicine
(89)
Infectious Diseases
(80)
Male
(74)
Female
(68)
Adult
(65)
Middle Aged
(55)
Biological And Medical Sciences
(53)
Medical Sciences
(53)
Human Immunodeficiency Virus
(51)
Anti-Hiv Agents - Therapeutic Use
(48)
Viral Diseases
(46)
Human Viral Diseases
(45)
Immunology
(44)
Hiv
(43)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(42)
Virology
(42)
Pharmacology. Drug Treatments
(40)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis

Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy

Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1

Pilot Pharmacokinetic Study of Human Immunodeficiency Virus-Infected Patients Receiving Tenofovir Disoproxil Fumarate (TDF): Investigation of Systemic and Intracellular Interactions between TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir

Immunodiscordant responses to HAART - mechanisms and consequences

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine

Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis

Compromised Immunologic Recovery in Treatment-Experienced Patients with HIV Infection Receiving Both Tenofovir Disoproxil Fumarate and Didanosine in the TORO Studies

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels

Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study

Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study)

Aktive Filter

Suchergebnisse filtern